Phase 1 Study of NGM313 in Healthy Adult Participants

Summary

The purpose of this study is to determine the safety and tolerability of NGM313, both single dose and multiple doses, in normal healthy overweight and obese adult participants.

Timeline

Start

2016-02

Primary completion

2017-04

Completion

2017-04

Drugs

Indications